TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $57K of Entrada Therapeutics, Inc.
Sold$56,559
$18.19Price
3,110Shares
−16%Stake
What TRDA did after the filing
- The stock from Tue, Dec 6 close, $17.17
- −22.1%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Jan 20 close.
Traded Fri, Dec 2. Filed Tue, Dec 6, 12:02 PM ET, during the session. Returns use the Dec 6 close and the Jan 20 close. Not investment advice.